Page last updated: 2024-10-27

furazolidone and Onchocerciasis

furazolidone has been researched along with Onchocerciasis in 1 studies

Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.

Onchocerciasis: Infection with nematodes of the genus ONCHOCERCA. Characteristics include the presence of firm subcutaneous nodules filled with adult worms, PRURITUS, and ocular lesions.

Research Excerpts

ExcerptRelevanceReference
"12 adult onchocerciasis patients from the rain forest zone of Nigeria were treated with furazolidone in divided daily doses ranging from 5--15 mg per kg body weight for 7--21 days to a maximum total dose of 6."7.66Failure of furazolidone in the treatment of onchocerciasis. ( Kale, OO, 1981)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kale, OO1

Other Studies

1 other study available for furazolidone and Onchocerciasis

ArticleYear
Failure of furazolidone in the treatment of onchocerciasis.
    Tropenmedizin und Parasitologie, 1981, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Animals; Female; Furazolidone; Humans; Male; Microfilariae; Middle Aged; Nigeria;

1981